Biotech news
Refine search
Americas
Law firm Lerner David Littenberg Krumholz & Mentlik has hired Tedd Van Buskirk as partner in its intellectual property practice in Westfield, New Jersey. 26 January 2016
Americas
Law firm Barnes & Thornburg has hired Scott Rothenberger and Jeffrey Stone as partners in the firm’s intellectual property department in Minneapolis. 22 January 2016
Americas
Law firm Hogan Lovells has hired Michael Dougherty and Tony Pezzano as partners in the firm’s intellectual property media and technology practice group in New York. 21 January 2016
Biotech
The European Patent Office has revoked Monsanto’s patent covering virus-resistant melons on technical grounds, following opposition to its registration by the Indian government and activist group No Patents on Seeds. 21 January 2016
Africa
Intellectual property rights should be used to help valorise agricultural biodiversity and traditional knowledge for the benefit of the global population as well as small farming communities around the world, says Graham Dutfield of the University of Leeds. 11 January 2016
Americas
Enzo Biochem has agreed a $9 million settlement with Agilent Technologies in a patent infringement lawsuit centring on technology used in detecting nucleic acid. 7 January 2016
Americas
Biopharmaceutical company Celgene and India-based rival Natco Pharma have settled a lawsuit centring on the alleged infringement of a number patents covering the Revlimid drug. 5 January 2016
Biotech
A grace period would give German inventors more flexibility to deal with different rules set by scientific publications and patenting procedures, and allow them to seek patent rights without the fear of prior disclosure, as Michael Kahnert of BIO Deutschland reports. 5 January 2016
Americas
Biopharmaceutical company Suven Life Sciences has been granted three product patents for the non-chemical entities for the treatment of neurodegenerative diseases including Alzheimer’s. 5 January 2016
Pharma
UK law firm Potter Clarkson has elected Michael Pears as partner in the firm’s biotechnology and pharmaceuticals department. 5 January 2016